{"name":"Ora Bio Ltd.","slug":"ora-bio-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ORA102 and Avastin","genericName":"ORA102 and Avastin","slug":"ora102-and-avastin","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ORA102 and Avastin","genericName":"ORA102 and Avastin","slug":"ora102-and-avastin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQUGlNZkxodXR0RlZoTkYzQlpqdmZlZmNkdGdaaU1BM0xwNkt1ZktiRVczUjdVU0tMZFg1YW1nSmRSV2V3aVY3WE9BSWhOUFlENlBfU0Vpd3hCeWxtQ3Zfb2tyVlMyOENmOUVhOEdOeW5nTEx3V0x0MFd0RllpVHRNYzl1bkpUTmJ6RUhKX1VTTUZMYjVmMDJvLWJ2b19qckVYSEljZTV3UVFXT3A0VlFFZ1pYYXZoS0VIU0NjNXZRVQ?oc=5","date":"2023-12-08","type":"regulatory","source":"Reuters","summary":"US FDA approves two gene therapies for sickle cell disease - Reuters","headline":"US FDA approves two gene therapies for sickle cell disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBtMkQ2eHlJbFpQcXpzWVlVM3pHc1Z6Zmh2akVMM3h5amxJbnc0QnZHWmxaVjhFZUlpYmotSDBVcUZwZTVWQ29tNzBBd3k2X1lLcjM0UUd0VGVsaWU5VzR6dGJpQVQ5MkpRNVVSbXVuYWRDdw?oc=5","date":"2020-07-01","type":"pipeline","source":"Fortune Business Insights","summary":"Biobetters Market Size, Industry Share, Forecast to 2034 - Fortune Business Insights","headline":"Biobetters Market Size, Industry Share, Forecast to 2034","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}